In continuous international expansion since 1998, Inke provides full support to its customers worldwide
Inke is part of Neuraxpharm, a leading European specialty pharmaceutical company in the treatment of central nervous system disorders (CNS) and consolidated as a group in 2016.
Neuraxpharm develops and commercializes branded and generic CNS pharmaceuticals and nutraceuticals related to the prevention of CNS indications.
Additionally, through its manufacturing companies Inke and Lesvi, Neuraxpharm has an international presence in more than 50 countries. It provides industry partners with niche active pharmaceutical ingredients (APIs) and finished dosage forms (FDFs) across multiple technologies.
Listed products protected by valid patents are developed solely for purposes related to the development, preparation and submission of information to obtain a Marketing Authorisation. In particular these products are under development for uses related to the activities stated in Art. 10.6 of Directive 2001/83/EC amended by the Directive 2004/27/EC of the European Parliament and of the Council of 31 March 2004, i.e. activities carried out to obtain a Marketing Authorisation. None of the products are offered for sale or supplied to countries in which they could be in conflict with valid patents.
© Neuraxpharm / INKE. All rights reserved.